Mitotech CSO to Present Visomitin® Data in Dry Eye Disease and Glaucoma
24 Feb 2022 //
GLOBENEWSWIRE
Mitotech & Essex Bio-Technology announce positive results of VISTA-2 Ph3 study
26 Feb 2021 //
PRWEB
24 Feb 2022 //
GLOBENEWSWIRE
26 Feb 2021 //
PRWEB